TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33289276

Group type: EXPERIMENTAL
Intervention: High-Flow Oxygen (HFOx)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-Flow Air (HFAir)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-Flow Oxygen (LFOx)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-Flow Air (LFAir)
Number of subjects: 17
Study: 33745228

Group type: EXPERIMENTAL
Intervention: Unguided web-based cognitive behavioral therapy (CBT) program for IBS
Number of subjects: 25
Study: 32757687

Group type: EXPERIMENTAL
Intervention: Echo Bi-Metric (EBM) THA stem
Number of subjects: 62

Group type: COMPARATOR
Intervention: Bi-Metric (BM) THA stem
Number of subjects: 62
Study: 34357466

Group type: EXPERIMENTAL
Intervention: Pantoprazole 80 mg with cisplatin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg with cisplatin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cisplatin without pantoprazole (Control group)
Number of subjects: 60
Study: 32513018

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 102
Study: 35085912

Group type: EXPERIMENTAL
Intervention: EBEKO application (mobile and web-based software system) used for 14 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 33757798

Group type: EXPERIMENTAL
Intervention: Ritlecitinib
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Brepocitinib
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 34516363

Group type: EXPERIMENTAL
Intervention: Brazil nut supplementation (1 Brazil nut/day)
Number of subjects: 36
Study: 32281641

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy during hospitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine replacement therapy after discharge
Number of subjects: 0
Study: 35148036

Group type: EXPERIMENTAL
Intervention: Whole-body OMT protocol (OMT-WB)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Neck-down OMT protocol (OMT-ND)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham treatment protocol
Number of subjects: 45
Study: 34691303

Group type: EXPERIMENTAL
Intervention: Flexible ureteroscopy combined with external physical vibration
Number of subjects: 146

Group type: COMPARATOR
Intervention: Flexible ureteroscopy lithotripsy
Number of subjects: 146
Study: 36151727

Group type: EXPERIMENTAL
Intervention: Simple task in simple environment
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Complex task in simple environment
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Simple task in complex environment
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Complex task in complex environment
Number of subjects: 162
Study: 32466710

Group type: EXPERIMENTAL
Intervention: Alcoholic drink (0.4 g/kg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 88
Study: 616854348

Group type: EXPERIMENTAL
Intervention: Kinesiotaping group (KG, tape applied with 40% tension for rectus femoris activation)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (CG, tape applied over rectus femoris without additional tension)
Number of subjects: 26
Study: 35339004

Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Pacing (LBBP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Right Ventricular Septal Pacing (RVSP)
Number of subjects: 50
Study: 32986231

Group type: EXPERIMENTAL
Intervention: Exercise intervention for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Relaxation intervention for 12 weeks
Number of subjects: 46
Study: 37318120

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with 8 mg intravenous ondansetron
Number of subjects: 212

Group type: COMPARATOR
Intervention: Ondansetron alone
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with ondansetron
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study: 32333793

Group type: EXPERIMENTAL
Intervention: Fish oil (2.5 g daily for four months)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 32940710

Group type: EXPERIMENTAL
Intervention: Trialstreamer system for finding and categorizing RCTs
Number of subjects: 673191

Group type: EXPERIMENTAL
Intervention: Trialstreamer system
Number of subjects: 673191
Study: 34313366

Group type: EXPERIMENTAL
Intervention: Lifestyle training package (60-90 min group training, educational booklet, text messages)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Lifestyle training package
Number of subjects: 140
Study: 34108247

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 25% nitrous oxide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (air/oxygen)
Number of subjects: 24
Study: 32682559

Group type: EXPERIMENTAL
Intervention: PEEPmaxCrs
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Individualised PEEP (PEEPmaxCrs and PEEPPtp_ee combined)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (PEEP≤2 cm H2O)
Number of subjects: 37
Study: 34428118

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (10-week program)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study: 33260552

Group type: EXPERIMENTAL
Intervention: Oolong tea (100 mg caffeine, 21.4 mg gallic acid, 97 mg catechins, 125 mg polymerized polyphenol)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34058114

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP-1 receptor agonists
Number of subjects: 0
Study: 34272336

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 2273
Study: 32665528

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32380994

Group type: EXPERIMENTAL
Intervention: Hip abductor strengthening exercises combined with quadriceps strengthening exercises
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standalone quadriceps strengthening exercises
Number of subjects: 86
Study: 35761199

Group type: EXPERIMENTAL
Intervention: Intradialysis exercise program with non-immersive virtual reality for 3 months
Number of subjects: 0
Study: 34693501

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.2 mg/kg three times daily, administered 15 min before feeding, up to term.
Number of subjects: 466

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 466
Study: 32064708

Group type: EXPERIMENTAL
Intervention: ACO (defined by various definitions including atopy and physician diagnosis of asthma)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Non-ACO (control group)
Number of subjects: 522
Study: 36172027

Group type: EXPERIMENTAL
Intervention: Idebenone (30 mg each time, three times a day)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 142
Study: 35379286

Group type: EXPERIMENTAL
Intervention: Intra-arterial vasodilatory therapy (prostaglandin infusion)
Number of subjects: 42
Study: 32430540

Group type: EXPERIMENTAL
Intervention: Alcohol (male: 0.55 g/kg, female: 0.45 g/kg)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control
Number of subjects: 111
Study: 32348239

Group type: EXPERIMENTAL
Intervention: LAPIP protocol
Number of subjects: 222
Study: 36350802

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction program for chronic back pain (MBSR-CBP)
Number of subjects: 96
Study: 33565516

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONSs)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no ONSs)
Number of subjects: 52
Study: 36358943

Group type: EXPERIMENTAL
Intervention: Pregnenolone (PREG) 500 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pregnenolone (PREG) 300 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 30
Study: 33353913

Group type: EXPERIMENTAL
Intervention: 31 gauge needle (31GN)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 31 gauge needle with topical lignocaine‐prilocaine (31GT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 27 gauge needle (27GN)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 27 gauge needle with topical lignocaine‐prilocaine (27GT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 31GN
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 31GT
Number of subjects: 100

Group type: COMPARATOR
Intervention: 27GN
Number of subjects: 100

Group type: COMPARATOR
Intervention: 27GT
Number of subjects: 100
Study: 35796486

Group type: EXPERIMENTAL
Intervention: Ketamine (75 mg) with 1 mg midazolam
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard Moderate Sedation (SMS) with midazolam and fentanyl (150 mcg fentanyl, 5 mg midazolam)
Number of subjects: 66
Study: 34143669

Group type: EXPERIMENTAL
Intervention: Crazy Taxi (CT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PositScience InSight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 0
Study: 32687974

Group type: EXPERIMENTAL
Intervention: Seamos Activas II intervention (theory- and technology-enhanced physical activity intervention)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Seamos Saludables PA print intervention (control)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Self-reported MVPA
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Objectively measured MVPA
Number of subjects: 199
Study: 34859459

Group type: EXPERIMENTAL
Intervention: High-dose intravenous selenium supplementation (3000 mcg after anesthesia induction, 1000 mcg upon ICU admission, and 1000 mcg daily in the ICU for a maximum of 14 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32471143

Group type: EXPERIMENTAL
Intervention: Serum ANP levels >64.6 pg/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum NT-proCNP levels >1.7 pg/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natriuretic peptides (ANP and NT-proCNP)
Number of subjects: 0
Study: 35037049

Group type: EXPERIMENTAL
Intervention: Maternal PCV-10
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Maternal PPV-23
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Maternal Placebo
Number of subjects: 347
Study: 33036845

Group type: COMPARATOR
Intervention: Opioid-only (OO) regimen
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Multimodal pain management (MMPM) regimen
Number of subjects: 216
Study: 36174873

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm based on YOLOv5 detection model
Number of subjects: 200
Study: 33785406

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with traumatic memory reactivation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT) with non-traumatic memory reactivation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Change in heart rate while listening to the script
Number of subjects: 28
Study: 35585705

Group type: EXPERIMENTAL
Intervention: Culturally and contextually situated multimedia approach
Number of subjects: 60
Study: 35094095

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Workplace Dialog Intervention (WDI)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: ACT + WDI
Number of subjects: 264

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 264
Study: 33000326

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 70

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 70
Study: 35862395

Group type: EXPERIMENTAL
Intervention: Participation in herbal remedy clinical trial
Number of subjects: 30
Study: 34398796

Group type: EXPERIMENTAL
Intervention: WeChat-supported platform, Medication Housekeeper (MediHK) for 4 weeks, including daily pain diaries, ADR forms every 3 days, and Brief Pain Inventory every 15 days.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: WeChat-supported platform, Medication Housekeeper (MediHK) for 4 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional care without reminders to fill out forms.
Number of subjects: 100
Study: 32499552

Group type: EXPERIMENTAL
Intervention: Subjective selective carious tissue removal using hand instruments (S)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Objective selective carious tissue removal using a self-limiting polymer bur (O)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both S and O interventions
Number of subjects: 115
Study: 35182889

Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive-behavioral therapy (ICBT) (iSOMA) for 8 weeks
Number of subjects: 156

Group type: COMPARATOR
Intervention: waitlist control group (WL)
Number of subjects: 156
Study: 34896645

Group type: EXPERIMENTAL
Intervention: Multi-disciplinary clinic care
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard-care
Number of subjects: 188
Study: 33599356

Group type: EXPERIMENTAL
Intervention: E6011 (12-week multiple ascending dose phase: 2, 5, 10, and 15 mg/kg intravenously every 2 weeks)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: E6011 (12-week multiple ascending dose phase)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: E6011 (40-week Extension phase at the same dose as MAD phase)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: E6011 (during the study)
Number of subjects: 28
Study: 33248978

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (EES)
Number of subjects: 232
Study: 36283712

Group type: EXPERIMENTAL
Intervention: Pudendal block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Caudal block
Number of subjects: 60
Study: 35351839

Group type: EXPERIMENTAL
Intervention: Cervical Disk Arthroplasty (CDA)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Minimally Invasive Posterior Cervical Foraminotomy (MI‐PCF)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Open Posterior Cervical Foraminotomy (O‐PCF)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Anterior Cervical Decompression and Fusion (ACDF)
Number of subjects: 384

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 384
Study: 32406965

Group type: EXPERIMENTAL
Intervention: CHoBI7 mHealth program (mobile messages)
Number of subjects: 1777
Study: 35441808

Group type: EXPERIMENTAL
Intervention: taVNS (left ear, 10 Hz, 300 µs, 2.0–2.5 mA, 30 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: sham-taVNS (electrode attached to ear with the stimulator turned off)
Number of subjects: 26
Study: 33753275

Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and screw fixation)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonoperative treatment (pressure bandage)
Number of subjects: 45
Study: 32243100

Group type: EXPERIMENTAL
Intervention: Tolvaptan add-on (n = 25)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional diuretic therapy (n = 26)
Number of subjects: 51
Study: 34537912

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing and Cognitive Behavioral intervention (Project PLUS), 6 sessions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 84

Group type: COMPARATOR
Intervention: No-Intervention comparison cohort
Number of subjects: 84
Study: 33632926

Group type: EXPERIMENTAL
Intervention: gilteritinib
Number of subjects: 138
Study: 33002002

Group type: EXPERIMENTAL
Intervention: HIV-exposed infants
Number of subjects: 1852

Group type: EXPERIMENTAL
Intervention: HIV-exposed children
Number of subjects: 1852

Group type: COMPARATOR
Intervention: HIV-unexposed children
Number of subjects: 1852

Group type: EXPERIMENTAL
Intervention: Disclosure of mother’s HIV status
Number of subjects: 1852
Study: 32773594

Group type: EXPERIMENTAL
Intervention: Tapentadol extended-release (ER) 50 mg × 2
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Oxycodone controlled-release (CR) 10 mg × 2
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 34976333

Group type: EXPERIMENTAL
Intervention: X-ray examination results
Number of subjects: 152000

Group type: EXPERIMENTAL
Intervention: CT examination results
Number of subjects: 152000
Study: 32102119

Group type: EXPERIMENTAL
Intervention: Reablement group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Reminding group
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study: 35701794

Group type: EXPERIMENTAL
Intervention: Semi-sitting position
Number of subjects: 116

Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 116
Study: 33789722

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) injection into the cricopharyngeal muscle
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 44
Study: 32214382

Group type: EXPERIMENTAL
Intervention: Cervicovaginal microbiome characteristics (specifically Lactobacillus iners)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Cervicovaginal microbiome characteristics (specifically Gardnerella)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Increased microbial Shannon diversity at Visit 2 (V2)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: V1 genus Lactobacillus
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: V1 fungal diversity
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: V1 functional Cell Motility pathway
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: V2 bacterial diversity
Number of subjects: 273
Study: 34651517

Group type: COMPARATOR
Intervention: PAR group (physical activity recommendation from WHO)
Number of subjects: 89

Group type: COMPARATOR
Intervention: HIIT group (high-intensity interval training)
Number of subjects: 89

Group type: COMPARATOR
Intervention: HIIT + EMS group (HIIT adding whole-body electromyostimulation training)
Number of subjects: 89
Study: 33671310

Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSEe) 300 mg/day for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSEe)
Number of subjects: 0
Study: 34658152

Group type: EXPERIMENTAL
Intervention: Early childhood intervention (Melbourne INFANT program)
Number of subjects: 542

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 542
Study: 33160804

Group type: EXPERIMENTAL
Intervention: hipEOS (3D)
Number of subjects: 51

Group type: COMPARATOR
Intervention: TraumaCad (2D)
Number of subjects: 51
Study: 32745202

Group type: EXPERIMENTAL
Intervention: Liraglutide (LIRA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Canagliflozin (CANA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Liraglutide plus Canagliflozin (CANA/LIRA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 45
Study: 35385522

Group type: EXPERIMENTAL
Intervention: PAPR equipped with a cooling device
Number of subjects: 10

Group type: COMPARATOR
Intervention: PAPR
Number of subjects: 10

Group type: COMPARATOR
Intervention: Replaceable particulate respirator
Number of subjects: 10
Study: 32814753

Group type: EXPERIMENTAL
Intervention: Prebiotics (partially hydrolyzed guar gum) for four weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prebiotics (partially hydrolyzed guar gum)
Number of subjects: 15
Study: 35468322

Group type: EXPERIMENTAL
Intervention: Tirzepatide 15 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Semaglutide 1 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 32440938

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine (Lido/Epi)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3% prilocaine with 0.03 IU/mL felypressin (Prilo/Fely)
Number of subjects: 0
Study: 36138482

Group type: EXPERIMENTAL
Intervention: Understanding Your Baby (UYB)
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 1130
Study: 33616687

Group type: EXPERIMENTAL
Intervention: Incongruent Stroop task (iSTG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Congruent Stroop task (cSTG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study: 32745768

Group type: EXPERIMENTAL
Intervention: Coffee A (787 mg CGAs/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coffee B (407 mg CGAs/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenolic acids and CGAs in vitro
Number of subjects: 0
Study: 35938207

Group type: EXPERIMENTAL
Intervention: E2 0.5/NETA 0.1
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 32977025

Group type: EXPERIMENTAL
Intervention: High frequency transcranial magnetic stimulation (HF rTMS)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham control (not explicitly detailed)
Number of subjects: 46
Study: 36308079

Group type: EXPERIMENTAL
Intervention: Vitamin C 20 mg·kg‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study: 33662244

Group type: EXPERIMENTAL
Intervention: MI Varnish®
Number of subjects: 44

Group type: COMPARATOR
Intervention: Duraphat Varnish®
Number of subjects: 44
Study: 32289297

Group type: EXPERIMENTAL
Intervention: Various LVAD interventions across major clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized stroke definitions and subtypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integration of neurologists in study design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thorough evaluations of stroke etiology using multimodality techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adoption of the National Institutes of Health Stroke Scale
Number of subjects: 0
Study: 34275577

Group type: EXPERIMENTAL
Intervention: Paired Associated Stimulation (PAS) with bilateral stimulation position
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paired Associated Stimulation (PAS) with ipsilesional stimulation position
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paired Associated Stimulation (PAS) with contralesional stimulation position
Number of subjects: 120
Study: 32115349

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 1512